| Effect of hydroxychloroquine in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 383 (21), 2030-2040, 2020 | 1470 | 2020 |
| COVID-19 prevention and treatment: a critical analysis of chloroquine and hydroxychloroquine clinical pharmacology NJ White, JA Watson, RM Hoglund, XHS Chan, PY Cheah, J Tarning PLoS medicine 17 (9), e1003252, 2020 | 113 | 2020 |
| Approximate models and robust decisions J Watson, C Holmes Statistical Science 31 (4), 465-489, 2016 | 102 | 2016 |
| Resolving the cause of recurrent Plasmodium vivax malaria probabilistically AR Taylor, JA Watson, CS Chu, K Puaprasert, J Duanguppama, NPJ Day, ... Nature communications 10 (1), 5595, 2019 | 92 | 2019 |
| Estimating the proportion of Plasmodium vivax recurrences caused by relapse: a systematic review and meta-analysis RJ Commons, JA Simpson, J Watson, NJ White, RN Price The American journal of tropical medicine and hygiene 103 (3), 1094, 2020 | 88 | 2020 |
| Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria CS Chu, AP Phyo, C Turner, HH Win, NP Poe, W Yotyingaphiram, ... Clinical Infectious Diseases 68 (8), 1311-1319, 2019 | 62 | 2019 |
| Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria CS Chu, AP Phyo, KM Lwin, HH Win, T San, AA Aung, R Raksapraidee, ... Clinical Infectious Diseases 67 (10), 1543-1549, 2018 | 62 | 2018 |
| Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria J Watson, WRJ Taylor, G Bancone, CS Chu, P Jittamala, NJ White PLoS neglected tropical diseases 12 (4), e0006440, 2018 | 61 | 2018 |
| Modelling primaquine-induced haemolysis in G6PD deficiency J Watson, WRJ Taylor, D Menard, S Kheng, NJ White elife 6, e23061, 2017 | 54 | 2017 |
| Non-adherence in non-inferiority trials: pitfalls and recommendations Y Mo, C Lim, JA Watson, NJ White, BS Cooper BMJ 370, 2020 | 49 | 2020 |
| The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance … RJ Commons, JA Simpson, K Thriemer, CS Chu, NM Douglas, T Abreha, ... BMC medicine 17, 1-13, 2019 | 40 | 2019 |
| Improving the diagnosis of severe malaria in African children using platelet counts and plasma PfHRP2 concentrations JA Watson, S Uyoga, P Wanjiku, J Makale, GM Nyutu, N Mturi, EC George, ... Science translational medicine 14 (654), eabn5040, 2022 | 37 | 2022 |
| Concomitant bacteremia in adults with severe falciparum malaria NH Phu, NPJ Day, PQ Tuan, NTH Mai, TTH Chau, L Van Chuong, H Vinh, ... Clinical Infectious Diseases 71 (9), e465-e470, 2020 | 35 | 2020 |
| Age, exposure and immunity M White, J Watson Elife 7, e40150, 2018 | 35 | 2018 |
| Concentration-dependent mortality of chloroquine in overdose JA Watson, J Tarning, RM Hoglund, FJ Baud, B Megarbane, JL Clemessy, ... Elife 9, e58631, 2020 | 33 | 2020 |
| Investigating causal pathways in severe falciparum malaria: A pooled retrospective analysis of clinical studies SJ Leopold, JA Watson, A Jeeyapant, JA Simpson, NH Phu, TT Hien, ... PLoS medicine 16 (8), e1002858, 2019 | 29 | 2019 |
| Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against Plasmodium vivax malaria GR Awab, F Aaram, N Jamornthanyawat, K Suwannasin, W Pagornrat, ... elife 10, e62448, 2021 | 27 | 2021 |
| A molecular barcode to inform the geographical origin and transmission dynamics of Plasmodium vivax malaria E Diez Benavente, M Campos, J Phelan, D Nolder, JG Dombrowski, ... PLoS genetics 16 (2), e1008576, 2020 | 27 | 2020 |
| Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled … WHK Schilling, P Jittamala, JA Watson, S Boyd, V Luvira, T Siripoon, ... The Lancet Infectious Diseases 24 (1), 36-45, 2024 | 23 | 2024 |
| Machine learning analysis plans for randomised controlled trials: detecting treatment effect heterogeneity with strict control of type I error JA Watson, CC Holmes Trials 21, 1-10, 2020 | 22* | 2020 |
Nicholas WhiteProfessor of Tropical Medicine, Mahidol and Oxford Universities在 tropmedres.ac 的电子邮件经过验证
